Literature DB >> 8570096

Amino-terminal region of the beta-amyloid precursor protein activates mitogen-activated protein kinase.

S M Greenberg1, W Q Qiu, D J Selkoe, A Ben-Itzhak, K S Kosik.   

Abstract

The secreted form of the beta-amyloid precursor protein (beta-APP) has previously been shown to stimulate mitogen-activated protein (MAP) kinases in PC-12 pheochromocytoma cells. The amino-terminal half of secreted beta-APP contains a region rich in cysteine residues reminiscent of cysteine-rich binding regions in other families of extracellular proteins. We found that reductive alkylation of disulfide linkages eliminated the ability of secreted beta-APP to activate MAP kinase. To confirm the role of the cysteine-rich amino-terminal region, fragments representing the amino- and carboxyl-terminal halves of secreted beta-APP were expressed in bacteria as fusion proteins and purified. Ten-minute treatment with the amino-terminal segment of beta-APP activated MAP kinase approximately 15-fold, while the carboxyl segment had no effect. The amino-terminal fragment, like intact secreted beta-APP, was substantially inactivated by reduction of sulfhydryl groups. These results suggest that the amino-terminal region of beta-APP is responsible for activation of MAP kinase and that it requires structural loops created by disulfide linkages for activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570096     DOI: 10.1016/0304-3940(95)11944-r

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

Review 1.  Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging.

Authors:  Donat Kögel; Thomas Deller; Christian Behl
Journal:  Exp Brain Res       Date:  2011-11-16       Impact factor: 1.972

Review 2.  The amyloid-beta precursor protein: integrating structure with biological function.

Authors:  Constanze Reinhard; Sébastien S Hébert; Bart De Strooper
Journal:  EMBO J       Date:  2005-10-27       Impact factor: 11.598

3.  Proteins that bind to the RERMS region of beta amyloid precursor protein.

Authors:  Monika Pawlik; Deborah A C Otero; Minkyu Park; Wolfgang H Fischer; Efrat Levy; Tsunao Saitoh
Journal:  Biochem Biophys Res Commun       Date:  2007-02-20       Impact factor: 3.575

Review 4.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

Review 5.  Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.

Authors:  Ahsan Habib; Darrell Sawmiller; Jun Tan
Journal:  J Neurosci Res       Date:  2016-08-17       Impact factor: 4.164

Review 6.  The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease.

Authors:  Vicky W-W Tsai; Heather L Scott; Richard J Lewis; Peter R Dodd
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

7.  Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway.

Authors:  J Mills; D Laurent Charest; F Lam; K Beyreuther; N Ida; S L Pelech; P B Reiner
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

Review 8.  Molecular mechanisms of neurodegeneration in Alzheimer's disease.

Authors:  Leslie Crews; Eliezer Masliah
Journal:  Hum Mol Genet       Date:  2010-04-22       Impact factor: 6.150

Review 9.  APP Receptor? To Be or Not To Be.

Authors:  Carole Deyts; Gopal Thinakaran; Angèle T Parent
Journal:  Trends Pharmacol Sci       Date:  2016-01-31       Impact factor: 14.819

10.  Secreted amyloid precursor protein β and secreted amyloid precursor protein α induce axon outgrowth in vitro through Egr1 signaling pathway.

Authors:  Stéphanie Chasseigneaux; Levent Dinc; Christiane Rose; Claude Chabret; Fanny Coulpier; Piotr Topilko; Gweltas Mauger; Bernadette Allinquant
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.